Neuroscience

Neurology, as an independent research area, is also divided into a number of different disciplines. One focus is on the study of neuronal diseases such as Parkinson‘s, epilepsy, Alzheimer‘s, multiple sclerosis and tumors.

Neurology thus represents a significant interface between classical medicine and a large number of scientific research areas. We at Hölzel Diagnostika would like to support you in your research. We offer you a unique variety of products and a service tailored to your needs.

We offer, among others:

Antibodies for the detection of proteins in protein misfolding diseases
Specific detection of biomarkers by ELISA for i.a. Amyloid ß40, BDNF, GFAP, S100B, NPY
Neurotransmitters of the central nervous system, among others. Glutamate, GABA, serotonin and dopamine

Name	Specific against	Appl.	Item no.	Amount	Price
Etrolizumab Biosimilar(Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody)	Other	ELISA, other	DCC-A289-5mg DCChemicals	5 mg	Login Compare	Etrolizumab Biosimilar(Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody)
BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)	Other		DCC-A293-1mg DCChemicals	1 mg	Login Compare	BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)
BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)	Other		DCC-A293-5mg DCChemicals	5 mg	Login Compare	BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)
Vilobelimab Biosimilar (Anti-Complement C5 Reference Antibody)	Other		DCC-A834-1mg DCChemicals	1 mg	Login Compare	Vilobelimab Biosimilar (Anti-Complement C5 Reference Antibody)
Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)	Other		DCC-A833-1mg DCChemicals	1 mg	Login Compare	Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)
Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)	Other		DCC-A832-1mg DCChemicals	1 mg	Login Compare	Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)
Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)	Other	Blocking, other	DCC-A831-1mg DCChemicals	1 mg	Login Compare	Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)
NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)	Other		DCC-A830-1mg DCChemicals	1 mg	Login Compare	NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)
Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)	Other		DCC-A816-1mg DCChemicals	1 mg	Login Compare	Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)
PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)	Other		DCC-A804-1mg DCChemicals	1 mg	Login Compare	PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)
10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)	Other		DCC-A803-1mg DCChemicals	1 mg	Login Compare	10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)
Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)	Other		DCC-A801-1mg DCChemicals	1 mg	Login Compare	Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)
Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)	Other		DCC-A833-5mg DCChemicals	5 mg	Login Compare	Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)
Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)	Other		DCC-A832-5mg DCChemicals	5 mg	Login Compare	Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)
Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)	Other	Blocking, other	DCC-A831-5mg DCChemicals	5 mg	Login Compare	Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)
NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)	Other		DCC-A830-5mg DCChemicals	5 mg	Login Compare	NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)
Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)	Other		DCC-A816-50mg DCChemicals	50 mg	Login Compare	Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)
PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)	Other		DCC-A804-5mg DCChemicals	5 mg	Login Compare	PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)
10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)	Other		DCC-A803-5mg DCChemicals	5 mg	Login Compare	10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)
Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)	Other		DCC-A801-5mg DCChemicals	5 mg	Login Compare	Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)
Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)	Other		DCC-A663-1mg DCChemicals	1 mg	Login Compare	Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)
Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)	Other		DCC-A663-5mg DCChemicals	5 mg	Login Compare	Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)
Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)	Other		DCC-A664-1mg DCChemicals	1 mg	Login Compare	Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)
Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)	Other		DCC-A664-5mg DCChemicals	5 mg	Login Compare	Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)
Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody )	Other		DCC-A672-1mg DCChemicals	1 mg	Login Compare	Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody )

Name Price

Etrolizumab Biosimilar(Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody)

Type
Clone
Specific against	Other
Appl.	ELISA, other
Host
Item no.	DCC-A289-5mg
Amount	5 mg
Available

BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A293-1mg
Amount	1 mg
Available

BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A293-5mg
Amount	5 mg
Available

Vilobelimab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A834-1mg
Amount	1 mg
Available

Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A833-1mg
Amount	1 mg
Available

Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A832-1mg
Amount	1 mg
Available

Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.	Blocking, other
Host
Item no.	DCC-A831-1mg
Amount	1 mg
Available

NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A830-1mg
Amount	1 mg
Available

Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A816-1mg
Amount	1 mg
Available

PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A804-1mg
Amount	1 mg
Available

10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A803-1mg
Amount	1 mg
Available

Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A801-1mg
Amount	1 mg
Available

Ravulizumab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A833-5mg
Amount	5 mg
Available

Pozelimab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A832-5mg
Amount	5 mg
Available

Crovalimab Biosimilar (Anti-Complement C5 Reference Antibody)

Type
Clone
Specific against	Other
Appl.	Blocking, other
Host
Item no.	DCC-A831-5mg
Amount	5 mg
Available

NGM621 Biosimilar (Anti-Complement C3 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A830-5mg
Amount	5 mg
Available

Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A816-50mg
Amount	50 mg
Available

PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A804-5mg
Amount	5 mg
Available

10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A803-5mg
Amount	5 mg
Available

Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A801-5mg
Amount	5 mg
Available

Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A663-1mg
Amount	1 mg
Available

Prasinezumab Biosimilar (Anti-Alpha-synuclein Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A663-5mg
Amount	5 mg
Available

Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A664-1mg
Amount	1 mg
Available

Cinpanemab Biosimilar (Anti-Alpha-synuclein Reference Antibody)

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A664-5mg
Amount	5 mg
Available

Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody )

Type
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A672-1mg
Amount	1 mg
Available

Neuroscience

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Neuroscience

Contact

About Hölzel

Service

Infodesk